Skip to Main Content

Paper Details

N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
Heart Rhythm
3
2021
Author NameAffiliation
Changyu ShenSmith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School
Changyu ShenSmith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School
Alfred E BuxtonHarvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2